Natural Capsules Board Approves FY26 Results, Reappoints Director, Appoints New CS
Natural Capsules Limited's Board approved FY26 audited standalone and consolidated results. Mr. Shri Laxminarayana Moondra was re-appointed as Whole-time Director for 3 years. M/s. Mallya & Mallya appointed Internal Auditors for FY27. Mr. Akshay Dutta is the new Company Secretary & Compliance Officer. 25,000 ESOP shares were allotted.
The re-appointment of a key director and the appointment of a new Company Secretary are important for corporate governance and operational stability. Approval of financial results is standard. The ESOP allotment is a routine corporate action. These factors collectively have a medium impact on the company's operations and investor perception.
The announcement details routine board meeting outcomes including financial results approval, director re-appointment, and auditor/company secretary appointments. While positive for management continuity and operational updates, there are no significant growth drivers or negative news, making the sentiment neutral.
Natural Capsules Limited announced the outcome of its Board Meeting held on May 27, 2026. The Board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
Key decisions included the re-appointment of Mr. Shri Laxminarayana Moondra as Whole-time Director for a term of three years, with a revision in his remuneration effective July 28, 2026, subject to shareholder approval at the upcoming Annual General Meeting (AGM). Additionally, M/s. Mallya & Mallya, Chartered Accountants, were appointed as Internal Auditors for the Financial Year 2026-27. Mr. Akshay Dutta was appointed as the Company Secretary & Compliance Officer, effective May 27, 2026.
The Nomination Remuneration & Compensation Committee also approved the allotment of 25,000 equity shares under the Employee Stock Option Plan 2025. This allotment increased the company's paid-up share capital from ₹10,38,61,540 to ₹10,41,11,540. The Board Meeting commenced at 3:13 PM and concluded at 7:18 PM. The date and time for the ensuing AGM will be intimated in due course.
What to do with a filing like this
Natural Capsules Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Natural Capsules Limited. Read the original for the full detail.